Mark Ball, MD, FACS(@markballmd) 's Twitter Profileg
Mark Ball, MD, FACS

@markballmd

Urologic Oncologist at NCI | Assoc Prof & Fellowship APD | Social Media Editor @uroloncol | #kidneycancer #pheo surgery & translational genomics 🧬 Views mine

ID:156140673

linkhttps://www.ncbi.nlm.nih.gov/myncbi/1XQido827nPQ4/bibliography/public/ calendar_today16-06-2010 03:41:18

1,4K Tweets

2,8K Followers

488 Following

Mark Ball, MD, FACS(@markballmd) 's Twitter Profile Photo

N.B. surgeons. I used to have neck pain after long cases, but rarely if ever after prioritizing strength training.

account_circle
Mark Ball, MD, FACS(@markballmd) 's Twitter Profile Photo

Thanks for featuring our work led by super 🌟Jessica Hsueh (she/her) Georgetown Medicine NIH CC MedEd. Large language models can augment your research (and will be even better in the future). Her work showed that they can help identify post-operative complications (but not perfect yet for

account_circle
NCI Center for Cancer Research(@NCIResearchCtr) 's Twitter Profile Photo

: Congratulations to Dr. Ramaprasad Srinivasan for being appointed as a CCR Deputy Director! 👏 Dr. Srinivasan's commitments to developing targeted treatments for and increasing diversity in our are greatly admired.

#CCRNews: Congratulations to Dr. Ramaprasad Srinivasan for being appointed as a CCR Deputy Director! 👏 Dr. Srinivasan's commitments to developing targeted treatments for #KidneyCancer and increasing diversity in our #ClinicalTrials are greatly admired.
account_circle
Mark Ball, MD, FACS(@markballmd) 's Twitter Profile Photo

Surgery in the time of ?

NCI Urologic Oncology Branch YUO fellow presents our experience with surgery after Hif2a inhibition.

-small subset of pts grow on drug 📈
-most are anemic pre-op 💉
-no increased transfusions or surgical morbidity 🩸
-hold drug 7-10

Surgery in the time of #belzutifan ? @NCICCR_UroOnc @SUO_YUO fellow #DanNethala presents our experience with surgery after Hif2a inhibition. -small subset of pts grow on drug 📈 -most are anemic pre-op 💉 -no increased transfusions or surgical morbidity 🩸 -hold drug 7-10
account_circle
Mark Ball, MD, FACS(@markballmd) 's Twitter Profile Photo

Fancy predictive algorithm to predict renal functional outcomes after PN? Ain’t nobody got time for that.

Nityam Rathi Cleveland Clinic Lerner College of Medicine presents simplified eGFR calculation:

GFR_new = .9 * GFR_pre

performs as well or better than multivariable algorithms.

Nice work from

Fancy predictive algorithm to predict renal functional outcomes after PN? Ain’t nobody got time for that. @RathiNityam @CleClinicLCM presents simplified eGFR calculation: GFR_new = .9 * GFR_pre performs as well or better than multivariable algorithms. Nice work from
account_circle
Katie Coleman(@kaydaustin) 's Twitter Profile Photo

I’ll be sharing my story and presenting on “Empathy in the Face of Uncertainty and the Power of Social Media” during the Patient Perspectives session on Sunday, at 2:53pm in The Square in case anyone at would like to join.

I’ll be sharing my story and presenting on “Empathy in the Face of Uncertainty and the Power of Social Media” during the Patient Perspectives session on Sunday, at 2:53pm in The Square in case anyone at #AUA24 would like to join.
account_circle
Mark Ball, MD, FACS(@markballmd) 's Twitter Profile Photo

Great work, Jessica Hsueh (she/her)! Side-by-side posters at (and both manuscripts just accepted too Urologic Oncology Urology Practice). Another rockstar and testament to the NIH CC MedEd program.

can help you build your outcomes database - but still needs considerable human

Great work, @JessicaHsueh923! Side-by-side posters at #aua24 (and both manuscripts just accepted too @UrolOncol @UrologyPractice). Another rockstar and testament to the @CCMedEd #MRSP program. #ai can help you build your outcomes database - but still needs considerable human
account_circle
Conquer Cancer, the ASCO Foundation(@ConquerCancerFd) 's Twitter Profile Photo

The first-ever funded research on renal medullary carcinoma (RMC), a rare kidney cancer, was launched by Dr. Pavlos Msaouel, a Conquer Cancer-funded researcher. The work he would ultimately use for the lifesaving treatment of one of his own patients. brnw.ch/21wJ6BY

The first-ever funded research on renal medullary carcinoma (RMC), a rare kidney cancer, was launched by Dr. @PavlosMsaouel, a Conquer Cancer-funded researcher. The work he would ultimately use for the lifesaving treatment of one of his own patients. brnw.ch/21wJ6BY
account_circle